Literature DB >> 2753698

Carcinoma of the skin of the head and neck with perineural invasion.

W M Mendenhall1, J T Parsons, N P Mendenhall, T A Brant, S P Stringer, N J Cassisi, R R Million.   

Abstract

This is an analysis of 25 patients with carcinoma of the skin of the head and neck with clinical evidence of perineural invasion, who were managed with curative intent by radiotherapy alone (16) or surgery and radiotherapy (9). All patients had a minimum of 5 years of follow-up. Local control following treatment was observed in 20% of patients treated with radiotherapy alone and 38% of those treated with surgery and radiotherapy. Local control was diminished for recurrent lesions and for tumors that also invaded bone and/or cartilage. The 5-year absolute survival rates were 31% for patients treated with radiotherapy alone and 33% for those in the combined-treatment group. The incidence of significant complications was similar: 25% with radiotherapy alone and 33% with surgery and adjuvant radiotherapy.

Entities:  

Mesh:

Year:  1989        PMID: 2753698     DOI: 10.1002/hed.2880110404

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Great auricular nerve: anatomy and imaging in a case of perineural tumor spread.

Authors:  L E Ginsberg; S A Eicher
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

Review 2.  Imaging of perineural spread in head and neck tumours.

Authors:  C K Ong; V F-H Chong
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

Review 3.  Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data.

Authors:  Pritesh S Karia; Frederick C Morgan; Emily Stamell Ruiz; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

Review 4.  Review of Perineural Invasion in Keratinocyte Carcinomas.

Authors:  Albert E Zhou; Karl M Hoegler; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2021-06-08       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.